VERACITY is a new generation non-invasive prenatal test, which, in addition to common fetal (Patau, Edwards, Down) trisomies 13,18,21, determines the risk of developing X, Y chromosome aneuploidy and microdeletions (DiGeorge, 1p36, Smith-Magenis, Wolfhirschorn).
The VERACITY test is performed in singleton and twin pregnancies, including pregnancies obtained through in vitro fertilization and surrogacy (IVF). It can be performed from the 10th week of gestation and is safe for both the pregnant woman and the fetus.
- "Synevo" every Tuesday and Thursday of the week in prenatal care for pregnant womenი It's screening days!
- "Verasit" | "Veragen" - these tests determine with high accuracy the risk of developing genetic disorders of the fetus!
- In all branches of "Synevo" you can take advantage of a special discount of up to 45%!
Learn more: Prenatal screening What we need to know